Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP3272334

PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL-2 FAMILY INHIBITOR

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    8.6.2010
  • EP published:
    6.3.2019
  • EP application number:
    17181461.9
  • Max expiry date:
    7.6.2030
  • Title:
    PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL-2 FAMILY INHIBITOR

Timeline

Today
8.6.2010EP application
6.3.2019EP Publication

Owner

  • Name:
    AbbVie Deutschland GmbH & Co. KG
  • Address:
    Mainzer Strasse 81, 65189, Wiesbaden, DE

Inventor

  • Name:
    PACKHAEUSER, Claudia
  • Address:
    Mannheim, DE
  • Name:
    STEIGER, Norbert
  • Address:
    Lingenfeld, DE
  • Name:
    LIEPOLD, Bernd
  • Address:
    Dossenheim, DE
  • Name:
    KOSTELAC, Drazen
  • Address:
    Mannheim, DE
  • Name:
    KNOBLOCH, Martin
  • Address:
    Neuhofen, DE

Priority

  • Number:
    185130 P
  • Date:
    8.6.2009
  • Country:
    US

Classification

  • Categories:
    A61K 9/00, A61K 31/5377, A61K 9/14, A61K 9/20, A61K 9/48, A61K 31/635

Upload documents